Fentanyl Exposure and Detection Strategies Utilized by Clinical Trial Participants Seeking Linkage to Opioid Use Disorder Treatment at a Syringe Service Program

• Published in: Journal of medical toxicology 2024-01, Vol.20 (1), p.13-21
• Main Authors: Watson, Dennis P., Ray, Bradley, Phalen, Peter, Duhart Clarke, Sarah E., Taylor, Lisa, Swartz, James, Gastala, Nicole
• Format: Article
• Language: English
• Subjects: Analgesics, Opioid - therapeutic use; Biomedical and Life Sciences; Biomedicine; Clinical trials; Drug abuse; Drug addiction; Drug Overdose - diagnosis; Drug Overdose - epidemiology; Drug Overdose - therapy; Drugs; Exposure; Fentanyl; Humans; Narcotics; Opioid-Related Disorders - diagnosis; Opioid-Related Disorders - drug therapy; Opioid-Related Disorders - epidemiology; Opioids; Original; Original Article; Overdose; Pharmacology/Toxicology; Risk management; Risk reduction; Risk taking; Syringes; Urinalysis
• ISSN: 1556-9039; 1937-6995; 1937-6995
• DOI: 10.1007/s13181-023-00979-7

Introduction The USA continues to face a fentanyl-driven overdose epidemic. Prior research has demonstrated users of illicit opioids are concerned about fentanyl exposure and overdose, but the strategies they report using to detect fentanyl’s presence lack empirical support. This study compares self-report and biologically detected fentanyl use and investigates overdose risk and risk reduction behaviors among a sample of high-risk people who use opioids. Methods Structured enrollment interviews conducted as part of a larger clinical trial assessed self-reported fentanyl exposure as well as strategies used to determine believed fentanyl exposure and prevent overdose among 240 participants enrolled at a Chicago, IL syringe service program. Urinalysis measured actual fentanyl exposure. Results Most participants identified as African American (66.7%) and had considerable overdose experience (76.7% lifetime and 48% in the past year). Most also tested positive for fentanyl (93.75%) despite reporting no past year use of fentanyl or fentanyl-adulterated drugs (64.17%). The most utilized approaches reported for identifying fentanyl exposure were stronger effects of the drug (60.7%), sight or taste (46.9%), and being told by someone using the same drugs (34.2%). Few participants (14%) reported using fentanyl test strips. No significant associations were identified between self-report and urinalysis measures or urinalysis results and risk reduction strategies. Conclusion This study adds to prior fentanyl exposure risk research. The disconnect between participants’ fentanyl detection methods and reported overdose experiences supports the need for more research to identify and understand factors driving access and use of overdose prevention resources and strategies.